Screener
Aquestive Therapeutics, Inc. AQST Raw materials
Raw materials at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryRawMaterials.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
FAQ
- What is Aquestive Therapeutics, Inc.'s raw materials?
- Aquestive Therapeutics, Inc. (AQST) reported raw materials of $4.21M in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s raw materials changed year-over-year?
- Aquestive Therapeutics, Inc.'s raw materials increased by 0.9% year-over-year, from $4.17M to $4.21M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s raw materials?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s raw materials has grown at a 31.8% compound annual growth rate (CAGR), from $789K to $3.14M.
- What does raw materials mean?
- Unprocessed materials and components purchased for use in manufacturing, valued at cost.
Ask your AI about Aquestive Therapeutics, Inc.'s raw materials.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude